AstraZeneca
AZN
#47
Rank
ยฃ209.41 B
Marketcap
ยฃ67.54
Share price
-1.60%
Change (1 day)
28.23%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ6.15 Billion

According to AstraZeneca's latest financial reports the company has ยฃ6.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ4.40 B-4.28%
2023-12-31ยฃ4.59 B-10.87%
2022-12-31ยฃ5.16 B8.87%
2021-12-31ยฃ4.73 B-19.16%
2020-12-31ยฃ5.86 B23.67%
2019-12-31ยฃ4.74 B7.58%
2018-12-31ยฃ4.40 B30.79%
2017-12-31ยฃ3.36 B-28.45%
2016-12-31ยฃ4.70 B3.5%
2015-12-31ยฃ4.55 B0.61%
2014-12-31ยฃ4.52 B-24.6%
2013-12-31ยฃ5.99 B17.9%
2012-12-31ยฃ5.08 B-29.87%
2011-12-31ยฃ7.25 B-5.29%
2010-12-31ยฃ7.66 B8.71%
2009-12-31ยฃ7.04 B135.18%
2008-12-31ยฃ2.99 B-0.1%
2007-12-31ยฃ2.99 B-23.55%
2006-12-31ยฃ3.92 B35.87%
2005-12-31ยฃ2.88 B5.28%
2004-12-31ยฃ2.74 B24.17%
2003-12-31ยฃ2.20 B-24.46%
2002-12-31ยฃ2.92 B10.89%
2001-12-31ยฃ2.63 B-11.61%
2000-12-31ยฃ2.98 B46.6%
1999-12-31ยฃ2.03 B-0.83%
1998-12-31ยฃ2.05 B179.7%
1997-12-31ยฃ0.73 B-24.77%
1996-12-31ยฃ0.97 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bristol-Myers Squibb
BMY
ยฃ12.40 B 101.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.26 B 83.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.69 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ3.34 B-45.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
ยฃ7.85 B 27.74%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
ยฃ7.45 B 21.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.95 B 126.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ5.81 B-5.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ2.97 B-51.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ7.33 B 19.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland